Wednesday, 19 April 2023

Trial Skin Cancer Vaccine Dramatically Reduced Melanoma Relapse in Patients Receiving Immunotherapy

A personalized skin cancer vaccine has almost halved the risk of death or relapse in patients with the deadliest form of melanoma. The trial involved men and women who had surgery to remove melanoma from lymph nodes or other organs and were at high risk of the disease returning. About 1.3 million Americans are currently […]

The post Trial Skin Cancer Vaccine Dramatically Reduced Melanoma Relapse in Patients Receiving Immunotherapy appeared first on Good News Network.



from Good News Network https://ift.tt/kDQIvx3
via IFTTT

No comments: